Cargando…

Digital diagnostics and artificial intelligence in prostate cancer treatment in 5 years from now

Detalles Bibliográficos
Autores principales:	Cimadamore, Alessia, Cheng, Liang, Scarpelli, Marina, Lopez-Beltran, Antonio, Montironi, Rodolfo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Editorial on Update on Molecular Classification and Individualized Treatments of Genitourinary Tumors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039614/ https://www.ncbi.nlm.nih.gov/pubmed/33850784 http://dx.doi.org/10.21037/tau-2021-01

Ejemplares similares

Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
por: Montironi, Rodolfo, et al.
Publicado: (2021)

Towards a new WHO classification of renal cell tumor: what the clinician needs to know—a narrative review
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Narrative review: update on immunotherapy and pathological features in patients with bladder cancer
por: Aurilio, Gaetano, et al.
Publicado: (2021)

Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?
por: Mollica, Veronica, et al.
Publicado: (2021)

Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States
por: Santoni, Matteo, et al.
Publicado: (2021)

TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?—a narrative review
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Current and future perspectives of digital microscopy with fluorescence confocal microscope for prostate tissue interpretation: a narrative review
por: Rocco, Bernardo, et al.
Publicado: (2021)

A narrative review of individualized treatments of genitourinary tumors: is the future brighter with molecular evaluations?
por: Giunchi, Francesca, et al.
Publicado: (2021)

Update on Prostate Cancer Diagnosis, Prognosis, and Prediction to Response to Therapy
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Lesson from the COVID-19 pandemic: pathologists need to build their confidence on working in a digital microscopy environment
por: Montironi, Rodolfo, et al.
Publicado: (2021)

Classifying retinopathy of prematurity
por: Molinari, Andrea, et al.
Publicado: (2017)

Classification and staging of retinoblastoma
por: Fabian, Ido Didi, et al.
Publicado: (2018)

Uropathologists During the COVID-19 Pandemic: What Can Be Learned in Terms of Social Interaction, Visibility, and Social Distance
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Long Non-coding RNAs in Prostate Cancer with Emphasis on Second Chromosome Locus Associated with Prostate-1 Expression
por: Cimadamore, Alessia, et al.
Publicado: (2017)

New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
por: Cimadamore, Alessia, et al.
Publicado: (2018)

Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians
por: Gasparrini, Silvia, et al.
Publicado: (2019)

Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer
por: Cimadamore, Alessia, et al.
Publicado: (2020)

PATH-07. Diagnostic and therapeutic value of cerebrospinal fluid biopsy in pediatric brain tumors
por: Li, Shaoqun, et al.
Publicado: (2022)

New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?
por: Aurilio, Gaetano, et al.
Publicado: (2020)

Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer
por: Mollica, Veronica, et al.
Publicado: (2019)

Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
por: Di Nunno, Vincenzo, et al.
Publicado: (2018)

Exploring Small Extracellular Vesicles for Precision Medicine in Prostate Cancer
por: Giulietti, Matteo, et al.
Publicado: (2018)

PATH-03. Clinically Tractable Outcome Prediction of Group 3/4 Medulloblastoma Based on TPD52 Immunohistochemistry: a Multicohort Study
por: Delaidelli, Alberto, et al.
Publicado: (2022)

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
por: Aurilio, Gaetano, et al.
Publicado: (2020)

Is There a Role for Immunotherapy in Prostate Cancer?
por: Rizzo, Alessandro, et al.
Publicado: (2020)

Extragastrointestinal stromal tumor presenting as an exophytic prostatic mass
por: Nguyen Thanh, Thao, et al.
Publicado: (2020)

Case series: Diffusion weighted MRI appearance in prostatic abscess
por: Singh, Paramjeet, et al.
Publicado: (2011)

Multimodality approach to imaging giant multilocular cystadenoma of the prostate: A rare entity
por: El-Asmar, Jose M., et al.
Publicado: (2019)

The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors
por: Giulietti, Matteo, et al.
Publicado: (2021)

Giant multilocular prostatic cystadenoma, a diagnosis to consider in large pelvic male masses
por: Portugal Teixeira, Inês, et al.
Publicado: (2019)

Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic
por: Cimadamore, Alessia, et al.
Publicado: (2021)

The AO Pediatric Comprehensive Classification of Long Bone Fractures (PCCF): Part I: Location and morphology of 2,292 upper extremity fractures in children and adolescents
por: Joeris, Alexander, et al.
Publicado: (2017)

The AO Pediatric Comprehensive Classification of Long Bone Fractures (PCCF): Part II: Location and morphology of 548 lower extremity fractures in children and adolescents
por: Joeris, Alexander, et al.
Publicado: (2017)

The AO Pediatric Comprehensive Classification of Long Bone Fractures (PCCF): Part III: Multifragmentary long bone fractures in children—a retrospective analysis of 2,716 patients from 2 tertiary pediatric hospitals in Switzerland
por: Audigé, Laurent, et al.
Publicado: (2017)

PATH-04. Array-based global DNA Methylation profiling of mouse brain tumors allows comparison to human tumors
por: Schoof, Melanie, et al.
Publicado: (2022)

PATH-02. Using DNA methylation profiling to define tumor type and appropriate treatment: a case report and review of the literature of a rare CNS CIC altered sarcoma
por: Brodwater, William, et al.
Publicado: (2022)

PATH-05 Challenge and clinical relevance of a non-matching classifier output in genome-wide DNA methylation analysis for CNS neoplasms in pediatric and adolescent patients
por: Drexler, Richard, et al.
Publicado: (2022)

PATH-06. Molecular subgrouping of medulloblastoma via low-depth whole genome bisulfite sequencing
por: Thompson, Dean, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_027kl3dtdkp0bj9vvmo5l5426i